On the Record · Bruker
Bruker acquisitions, on the record
The businesses Bruker bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.
Deals its annual reports describe
| Business | Deal | When | Value |
|---|---|---|---|
PhenomeX Inc. (renamed Bruker Cellular Analysis)Word for word“In October 2023 we acquired PhenomeX Inc., a functional cell biology company renamed Bruker Cellular Analysis or “BCA” that provides single-cell biology research tools to deliver deep insights into cellular function and new perspectives on phenomes and genotype-to-phenotype.” 10-K for 2023 | acquisition | — | — |
Biognosys AGWord for word“The 2023 acquisition of the Swiss-based Biognosys AG further enhances the post-processing portfolio with their industry leading software Spectronaut for DIA data analysis as well as granting access to important quality control tools like the iRT Kits, rounding out the workflow options from sample preparation until final data processing and interpretation.” 10-K for 2023 | acquisition | 2023 | — |
FasmatechWord for word“In 2023 Fasmatech was acquired gaining an additional R&D site in Athens as well as access to the Omnitrap technology allowing research into addition fragmentation methods.” 10-K for 2023 | acquisition | In 2023 | — |
PinPointWord for word“One of the initial key strategies centers on addressing the clinical and forensic toxicology market in the USA, aided by the acquisition of PinPoint with their ToxBox technology.” 10-K for 2023 | acquisition | — | — |
Prolab AGWord for word“In 2022, Prolab AG was acquired, a Swiss-based, microfluidics components manufacturer whose components are an integral part of the nanoElute nanoflow LC system and PepSep, a nanocolumns manufacturer to augment the proteomics workflow for the timsTOF platform.” 10-K for 2023 | acquisition | 2022 | — |
PreOmicsWord for word“This was further augmented by the 2022 acquisition of PreOmics, a company specializing in sample preparation with their iST-workflow for efficient and automatable sample clean-up as well as the beatbox enabling easy-to-use tissue lysis.” 10-K for 2023 | acquisition | 2022 | — |
Spectral Instruments ImagingWord for word“Furthermore, during 2024, we completed our acquisition of Spectral Instruments Imaging and Chemspeed Technologies AG, and the minority investment in NovAliX, which align with the segment's goals of expanding its technological capabilities, entering new markets, and enhancing its product portfolio.” 10-K for 2024 | acquisition | during 2024 | — |
Chemspeed Technologies AGWord for word“Furthermore, during 2024, we completed our acquisition of Spectral Instruments Imaging and Chemspeed Technologies AG, and the minority investment in NovAliX, which align with the segment's goals of expanding its technological capabilities, entering new markets, and enhancing its product portfolio.” 10-K for 2024 | acquisition | during 2024 | — |
Tornado Spectral Systems Inc.Word for word“Furthermore, during 2024, we completed our acquisition of Tornado Spectral Systems Inc. (Toronto, Canada), Nanophoton Corporation (Osaka, Japan), Dynamic Biosensors GmbH (Munich, Germany and Massachusetts, U.S.A.) as well as ELITechGroup in various locations.” 10-K for 2024 | acquisition | during 2024 | — |
Nanophoton CorporationWord for word“Furthermore, during 2024, we completed our acquisition of Tornado Spectral Systems Inc. (Toronto, Canada), Nanophoton Corporation (Osaka, Japan), Dynamic Biosensors GmbH (Munich, Germany and Massachusetts, U.S.A.) as well as ELITechGroup in various locations.” 10-K for 2024 | acquisition | during 2024 | — |
Dynamic Biosensors GmbHWord for word“Furthermore, during 2024, we completed our acquisition of Tornado Spectral Systems Inc. (Toronto, Canada), Nanophoton Corporation (Osaka, Japan), Dynamic Biosensors GmbH (Munich, Germany and Massachusetts, U.S.A.) as well as ELITechGroup in various locations.” 10-K for 2024 | acquisition | during 2024 | — |
ELITechGroupWord for word“on April 30, 2024, the Company completed the acquisition of ELITechGroup for total consideration transferred, net of cash acquired, of $931.2 million.” 10-K for 2024 | acquisition | April 30, 2024 | $931.2 million |
NanoString TechnologiesWord for word“During 2024 we acquired substantially all of the assets and rights associated with NanoString Technologies, a leading provider of life-science research solutions for spatial transcriptomics and gene expression analysis.” 10-K for 2024 | acquisition | During 2024 | — |
Nion LLCWord for word“Furthermore, during 2024, we acquired Nion LLC, a manufacturer of innovative high-end scanning transmission electron microscopes, enhancing Bruker’s product offerings in materials science research and providing the technology base for applications in electron diffraction crystallography.” 10-K for 2024 | acquisition | during 2024 | — |
PhenomeXWord for word“In 2023, the Company recorded a gain of $144.1 million, in connection with the PhenomeX acquisition, which closed on October 2, 2023.” 10-K for 2024 | acquisition | October 2, 2023 | — |
Recipe Chemicals + Instruments GmbHWord for word“Furthermore, during 2025, we completed our acquisition of Recipe Chemicals + Instruments GmbH (“Recipe”), AST Revolution, LLC, as well as certain other acquisitions and minority investments.” 10-K for 2025 | acquisition | 2025 | — |
AST Revolution, LLCWord for word“Furthermore, during 2025, we completed our acquisition of Recipe Chemicals + Instruments GmbH (“Recipe”), AST Revolution, LLC, as well as certain other acquisitions and minority investments.” 10-K for 2025 | acquisition | 2025 | — |
Biocrates Life Sciences GmbH, Ridom GmbH, RECIPE Chemicals + Instruments GmbH, and Molzym GmbH & Co. KGWord for word“As described in Management’s Report on Internal Control over Financial Reporting, management has excluded Biocrates Life Sciences GmbH, Ridom GmbH, RECIPE Chemicals + Instruments GmbH, and Molzym GmbH & Co. KG from its assessment of internal control over financial reporting as of December 31, 2025 because they were acquired by the Company in purchase business combinations during 2025.” 10-K for 2025 | acquisition | 2025 | — |
| Fiscal year ended | Cash paid for acquisitions (net of cash acquired) | Goodwill from acquisitions |
|---|---|---|
| 2016-12-31 | $24.3 million | — |
| 2017-12-31 | $66.3 million | $33.8 million |
| 2018-12-31 | $191.6 million | $109 million |
| 2019-12-31 | $90 million | $19.7 million |
| 2020-12-31 | $59.2 million | $13.7 million |
| 2021-12-31 | $65 million | $30 million |
| 2022-12-31 | $182.3 million | $131.9 million |
| 2023-12-31 | $226.6 million | $114.1 million |
| 2024-12-31 | $1.6 billion | $958.3 million |
| 2025-12-31 | $73.9 million | $49 million |
Deal filings since 2016
- 2024-06-05 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-05-31 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-04-22 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-04-02 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-02-12 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-02-02 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-01-19 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2023-12-26 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2021-12-08 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2019-12-12 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2019-02-11 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
Read from Bruker’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-27. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.